Dicerna Pharmaceuticals, Inc. Net Profit Margin 2013-2021 | DRNA
Dicerna Pharmaceuticals, Inc. net profit margin from 2013 to 2021. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2021-09-30 | $0.19B | $-0.13B | -64.77% |
| 2021-06-30 | $0.18B | $-0.13B | -72.63% |
| 2021-03-31 | $0.18B | $-0.12B | -67.98% |
| 2020-12-31 | $0.16B | $-0.11B | -68.90% |
| 2020-09-30 | $0.13B | $-0.12B | -89.23% |
| 2020-06-30 | $0.09B | $-0.13B | -140.45% |
| 2020-03-31 | $0.06B | $-0.12B | -212.73% |
| 2019-12-31 | $0.02B | $-0.12B | -504.17% |
| 2019-09-30 | $0.02B | $-0.10B | -526.32% |
| 2019-06-30 | $0.01B | $-0.09B | -676.92% |
| 2019-03-31 | $0.01B | $-0.10B | -1111.11% |
| 2018-12-31 | $0.01B | $-0.09B | -1125.00% |
